For example, at cut of values of above 5% of tumour cells with positive staining, dual expression of EGFR/HER-2, EGFR/HER-3 and EGFR/HER-4 were present at 62%, 45%, and 28% of the cases examined respectively (Table 3). This evidence concerns the gene ERBB3 and neoplasm.